Does TERAZOSIN Cause Dyspnoea? 60 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Dyspnoea have been filed in association with TERAZOSIN (terazosin). This represents 11.3% of all adverse event reports for TERAZOSIN.
60
Reports of Dyspnoea with TERAZOSIN
11.3%
of all TERAZOSIN reports
1
Deaths
33
Hospitalizations
How Dangerous Is Dyspnoea From TERAZOSIN?
Of the 60 reports, 1 (1.7%) resulted in death, 33 (55.0%) required hospitalization, and 11 (18.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TERAZOSIN. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does TERAZOSIN Cause?
Therapeutic product effect incomplete (75)
Asthma (66)
Drug ineffective (56)
Dizziness (47)
Cough (46)
Chest pain (42)
Malaise (40)
Hospitalisation (37)
Drug hypersensitivity (36)
Hypotension (36)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which TERAZOSIN Alternatives Have Lower Dyspnoea Risk?
TERAZOSIN vs TERAZOSIN\TERAZOSIN
TERAZOSIN vs TERBINAFINE
TERAZOSIN vs TERBINAFINE\TERBINAFINE
TERAZOSIN vs TERBUTALINE
TERAZOSIN vs TERCONAZOLE